| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3396053 | Antibiotiques | 2009 | 7 Pages |
Abstract
The discovery of new bactericidal drugs has an impact on treatment durations, especially in HIV patients: there is a need for non toxic molecules which do not interact with antiretroviral drugs (protease inhibitors and non-nucleosidic inhibitors) and permitting the optimisation of treatment durations.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
W. Sougakoff,